Breaking News Instant updates and real-time market news.

MYL

Mylan

$31.36

-0.31 (-0.98%)

07:18
11/06/18
11/06
07:18
11/06/18
07:18

Mylan upgraded to Buy after 'encouraging' Q3 report at BofA/Merrill

As previously reported, BofA Merrill Lynch analyst Jason Gerberry upgraded Mylan to Buy from Neutral, stating that its Q3 report provided encouraging updates regarding several of its business segments. He believes concerns around its broader portfolio look overdone as industry-level generic pricing is showing signs of stabilizing while the company also provided encouraging new product updates. Gerberry added that he views the 20% stock pullback as an attractive opportunity, but trimmed his price target on Mylan shares to $42 from $44 to reflect rebasing of EpiPen and generic Copaxone.

  • 13

    Nov

MYL Mylan
$31.36

-0.31 (-0.98%)

11/01/18
WELS
11/01/18
NO CHANGE
WELS
Market Perform
Fear of missing out helping to push Teva, Mylan higher, says Wells Fargo
Wells Fargo analyst David Maris believes Teva (TEVA) shares are bouncing back to fair value from recent declines after the company reported Q3 earnings that beat his above consensus estimate and hosted a "surprisingly bullish" quarterly call. He also sees a spillover effect occurring with Mylan (MYL) as the generic sector's advance reinforces buyers' belief that the stocks are undervalued and investors' "fear of missing out" drives increased interest. While Maris acknowledges Ajovy, Austedo, cost cuts and tax management are doing well, he believes much of Teva's business continues to show significant challenges and keeps a Market Perform rating on the shares.
11/06/18
JPMS
11/06/18
NO CHANGE
Target $45
JPMS
Overweight
Mylan Q3 better than feared, recent selloff overdone, says JPMorgan
JPMorgan analyst Chris Schott views Mylan's Q3 results as "better than feared" and a "step in the right direction." While the company's North American business remains under pressure, year-over-year erosion for the business improved from Q2, overall gross margins showed solid year-over-year improvement and Mylan maintained its annual guidance, Schott tells investors in a post-earnings research note. The analyst views the recent weakness in the shares as overdone and keeps an Overweight rating on the name with a $45 price target. Looking beyond near-term challenges, Mylan is one of the better-positioned players in the space with a number of longer-term growth drivers in place, including biosimilars and the pending generic Advair approval, says Schott.
11/06/18
MZHO
11/06/18
NO CHANGE
Target $39
MZHO
Neutral
Mylan target raised to $39 on 'comforting' Q3 results at Mizuho
Mylan reported "comforting" Q3 results with $300M in high margin new product sales and reiterated its 2018 guidance, Mizuho analyst Irina Koffler tells investors in a post-earnings research note. The analyst raised her price target for the shares to $39 from $37 and reiterates a Neutral rating on the name.
11/06/18
BOFA
11/06/18
UPGRADE
BOFA
Buy
Mylan upgraded to Buy from Neutral at BofA/Merrill

TODAY'S FREE FLY STORIES

EVFM

Evofem

$3.45

0.01 (0.29%)

06:05
11/19/18
11/19
06:05
11/19/18
06:05
Conference/Events
Evofem management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 27

    Nov

YETI

Yeti

$16.99

0.1 (0.59%)

06:05
11/19/18
11/19
06:05
11/19/18
06:05
Initiation
Yeti initiated  »

Yeti initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

BPY

Brookfield Property

$18.48

-0.04 (-0.22%)

06:04
11/19/18
11/19
06:04
11/19/18
06:04
Conference/Events
Brookfield Property management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

PGR

Progressive

$66.28

-0.03 (-0.05%)

06:04
11/19/18
11/19
06:04
11/19/18
06:04
Upgrade
Progressive rating change  »

Progressive upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVTR

Nuvectra

$18.43

0.29 (1.60%)

06:04
11/19/18
11/19
06:04
11/19/18
06:04
Initiation
Nuvectra initiated  »

Nuvectra initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

ESRX

Express Scripts

$97.66

0.23 (0.24%)

06:04
11/19/18
11/19
06:04
11/19/18
06:04
Hot Stocks
Express Scripts announces strategic alliance with Petco for pet medicine »

Petco and Express Scripts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATVI

Activision Blizzard

$50.95

-2.6 (-4.86%)

06:04
11/19/18
11/19
06:04
11/19/18
06:04
Conference/Events
Activision Blizzard management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

TPC

Tutor Perini

$17.82

0.22 (1.25%)

06:04
11/19/18
11/19
06:04
11/19/18
06:04
Hot Stocks
Tutor Perini awarded $799.5M contract for Southwest Light Rail Transit project »

Tutor Perini announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PJT

PJT Partners

$46.44

0.01 (0.02%)

06:03
11/19/18
11/19
06:03
11/19/18
06:03
Upgrade
PJT Partners rating change  »

PJT Partners upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIG

Big Lots

$41.49

-0.58 (-1.38%)

06:03
11/19/18
11/19
06:03
11/19/18
06:03
Upgrade
Big Lots rating change  »

Big Lots upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMPL

Simply Good Foods

$19.99

0.42 (2.15%)

06:03
11/19/18
11/19
06:03
11/19/18
06:03
Initiation
Simply Good Foods initiated  »

Simply Good Foods…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JWN

Nordstrom

$50.91

-8.06 (-13.67%)

06:03
11/19/18
11/19
06:03
11/19/18
06:03
Upgrade
Nordstrom rating change  »

Nordstrom upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QEP

QEP Resources

$8.38

-0.03 (-0.36%)

06:02
11/19/18
11/19
06:02
11/19/18
06:02
Hot Stocks
QEP Resources to sell NW Louisiana natural gas assets to Aethon III for $735M »

QEP Resources announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TI

Telecom Italia

$6.02

0.12 (2.03%)

, VIVHY

Vivendi

$0.00

(0.00%)

06:02
11/19/18
11/19
06:02
11/19/18
06:02
Periodicals
Paul Singer scores win with new Telecom Italia CEO, NY Post reports »

Paul Singer was handed a…

TI

Telecom Italia

$6.02

0.12 (2.03%)

VIVHY

Vivendi

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRWD

Ironwood

$11.96

0.32 (2.75%)

06:01
11/19/18
11/19
06:01
11/19/18
06:01
Recommendations
Ironwood analyst commentary  »

Ironwood price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

06:00
11/19/18
11/19
06:00
11/19/18
06:00
General news
FX Action: USD-JPY has retained a heavy tone »

FX Action: USD-JPY has…

YETI

Yeti

$16.99

0.1 (0.59%)

05:59
11/19/18
11/19
05:59
11/19/18
05:59
Initiation
Yeti initiated  »

Yeti initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

RHHBY

Roche

$0.00

(0.00%)

05:57
11/19/18
11/19
05:57
11/19/18
05:57
Downgrade
Roche rating change  »

Roche downgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Dec

  • 24

    Dec

NVS

Novartis

$87.74

0.52 (0.60%)

05:56
11/19/18
11/19
05:56
11/19/18
05:56
Upgrade
Novartis rating change  »

Novartis upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 03

    Dec

TI

Telecom Italia

$6.02

0.12 (2.03%)

05:53
11/19/18
11/19
05:53
11/19/18
05:53
Hot Stocks
Telecom Italia appoints Luigi Gubitosi as CEO »

On Sunday, the company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STNE

StoneCo

$25.31

0.69 (2.80%)

05:51
11/19/18
11/19
05:51
11/19/18
05:51
Initiation
StoneCo initiated  »

StoneCo initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

AZN

AstraZeneca

$40.67

-0.685 (-1.66%)

05:51
11/19/18
11/19
05:51
11/19/18
05:51
Downgrade
AstraZeneca rating change  »

AstraZeneca downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 03

    Dec

JPDYY

Japan Display

$0.00

(0.00%)

05:49
11/19/18
11/19
05:49
11/19/18
05:49
Downgrade
Japan Display rating change  »

Japan Display downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTRX

Retrophin

$25.17

0.44 (1.78%)

05:46
11/19/18
11/19
05:46
11/19/18
05:46
Initiation
Retrophin initiated  »

Retrophin initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jun

YETI

Yeti

$16.99

0.1 (0.59%)

05:43
11/19/18
11/19
05:43
11/19/18
05:43
Initiation
Yeti initiated  »

Yeti initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.